Scripsamerica Inc (SCRC) 0.1575 $SCRC
ScripsAmerica Secures $4 Million Line of Credit From Triumph Healthcare Finance
Marketwired - Wed Dec 10, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off its current high interest debt.
ScripsAmerica's Specialty Pharmacy Records Over $5 Million in Approved Orders for the Third Consecutive Month
Marketwired - Wed Dec 03, 7:03AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,257,753 in approved orders during November of 2014. This represents the third consecutive month that ScripsAmerica's specialty pharmacy generated over $5 million in sales.
WSA Speaks to Three Companies on the Rise
Marketwired - Tue Dec 02, 10:27AM CST
ClearOne (NASDAQ: CLRO) CEO Zee Hakimoglu discussed the company's favorable Q3 results reporting 27% revenue growth from last year with solid profitability. She outlined ClearOne's products and patents and talked about two recent acquisitions and how these acquisitions have positioned ClearOne favorably in their traditional audio conferencing market as well as in the emerging media collaboration market.
CLRO: 9.74 (-0.02)
SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20
ACCESSWIRE - Tue Dec 02, 8:01AM CST
New York, NY / ACCESSWIRE / December 2, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on ScripsAmerica, Inc. (OTCQB: SCRC) with a 12-month price target of $1.20.
ScripsAmerica Exercises Option to Acquire 90% of PIMD International, LLC
Marketwired - Mon Dec 01, 7:01AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that it has exercised an option to acquire 90% of PIMD International, LLC, ("PIMD"
, a Florida-based pharmaceutical wholesaler that the Company has had a working relationship with since the fourth quarter of 2013.
ScripsAmerica Highlights CEO Interviews From Recent Investor Conference
Marketwired - Tue Nov 25, 7:00AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that its CEO, Bob Schneiderman, recently conducted interviews with financial outlets 'Stock News Now' (SNN) and 'New to the Street' (NTTS) at the SeeThru Equity Conference in NY.
ScripsAmerica Comments on Financial Results for the Third Quarter of 2014
Marketwired - Wed Nov 19, 3:51PM CST
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the third quarter ended September 30, 2014.
ScripsAmerica Announces Full Acquisition of Main Avenue Pharmacy
Marketwired - Wed Nov 19, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has recently acquired 100% of Main Avenue Pharmacy, Inc. ("MAVP" , a New Jersey-based pharmacy that specializes in prescription topical creams.
ScripsAmerica Announces Conference Call to Provide Business Update and Discuss Third Quarter Fiscal 2014 Results
Business Wire - Mon Nov 17, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that it will host a conference call at 10 a.m. Eastern Time, Wednesday, December 3, 2014 to comment on current business conditions and market drivers and to discuss various initiatives of the Company. Robert Schneiderman, Chief Executive Officer, Founding Partner and Jeffrey Andrews, Chief Financial Officer will also discuss the Company's recent 10-Q filing for the third quarter ended September 30, 2014 and conduct a question and answer session.
"New To The Street" Is Back on the Street
Marketwired - Thu Nov 13, 12:40PM CST
"New To The Street" was back on the street in NYC outside the See Thru Equity Conference, seethruequity.com, on 45th Street, interviewing several CEO's who were presenting at the micro-cap conference. We will be featuring these interviews on our website, NewToTheStreet.com on our segment called "On the Street Interviews."
DSKX: 0.69 (+0.01)
Small Cap Traders Provides Brief Report on ScripsAmerica
PR Newswire - Wed Nov 05, 6:00AM CST
Analyst Brief by Small Cap Traders. -- ScripsAmerica, Inc. (OTCBB: SCRC) is a supplier of prescription, OTC and nutraceutical drugs incepted in 2008 in the US. The firm provides pharmaceutical products to a wide range of end users including retail pharmacies, hospitals, long-term care facilities, government, and home care agencies. After experiencing a significant drop in profit margins in 2013, the firm restructured and has been experiencing a tremendous growth in both revenue and profit since the beginning of 2014. Q2 2014, ScripsAmerica reported $3,700,721 in total net revenue in compared to $91,628 reported during the same period in 2013, marking an increase of $3,609,093 in quarterly revenue. Also, profit margin in Q2 is 87%, in compare with a loss in 2013, signaling a positive trend for the firm. This growth in margin contributed to its management of the specialty pharmacy business which generated significant sales in the first six months of 2014.
Ironridge Global Partners, LLC Successfully Prevails in Federal Court Against Claims By ScripsAmerica, Inc.
ACCESSWIRE - Tue Nov 04, 3:03PM CST
LOS ANGELES, CA / ACCESSWIRE / November 4, 2014 / Ironridge Global Partners, LLC, an institutional investor in micro-cap public companies, today announced that the U.S. District Court has entered an order in favor of Ironridge Global Partners, granting its motion to dismiss the frivolous securities fraud claims filed by ScripsAmerica, Inc. (OTCQB: SCRC) in federal court, after ScripsAmerica's baseless claims against Ironridge Global IV, Ltd. had already been rejected by the California Superior Court.
ScripsAmerica Reports $5.6 Million in Approved Orders for Its Specialty Pharmacy in October
Marketwired - Tue Nov 04, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $5,619,052 in approved orders during the month of October 2014, representing growth of 3% over the previous month and increasing its annual run rate to $67.4 million.
ScripsAmerica to Present at SeeThruEquity Microcap Investor Conference
Marketwired - Tue Oct 28, 7:06AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company will present at the SeeThruEquity Microcap Investor Conference to be held on Wednesday, November 12th at the Convene Midtown East in New York City.
ScripsAmerica's Specialty Pharmacy Reports $5.5 Million in Approved Orders for the Month of September
Marketwire - Mon Oct 06, 7:00AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $5,457,137 in approved orders during the month of September 2014. The pharmacy's September revenue represented a 12% increase over the previous month and increased its annual run rate to over $65 million.
ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement
Marketwire - Tue Sep 16, 7:02AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has entered into a prescription sourcing agreement with Ohio-based Jungle Jim's International Market, which has pharmacy licenses in several states.
ScripsAmerica Expands Specialty Pharmacy Operations Through Prescription Sourcing Agreement With United Apothecary, Inc.
Marketwire - Mon Sep 08, 7:03AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has signed a prescription sourcing agreement with United Apothecary, Inc., a pharmacy based in Oak Ridge, TN.
ScripsAmerica's Specialty Pharmacy Continues Revenue Growth With $4.9 Million in Approved Orders for August
Marketwire - Wed Sep 03, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,867,637 in approved orders during the month of August 2014, marking its fifth consecutive month of sales growth.
ScripsAmerica Comments on 10-Q for the Second Quarter of 2014
Marketwire - Mon Aug 18, 7:01AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the second quarter ended June 30, 2014.
Ironridge Global IV, Ltd. Successfully Obtains Final Enforcement Order Against ScripsAmerica, Inc.
ACCESSWIRE - Wed Aug 13, 3:31PM CDT
Los Angeles, CA / ACCESSWIRE / August 13, 2014 / Ironridge Global IV, Ltd. has obtained a final order against ScripsAmerica, Inc. (OTCBB: SCRC), fully upholding the original stipulated settlement agreement of the parties.
ScripsAmerica Secures $4 Million Line of Credit From Triumph Healthcare Finance
Marketwired - Wed Dec 10, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off its current high interest debt.
ScripsAmerica's Specialty Pharmacy Records Over $5 Million in Approved Orders for the Third Consecutive Month
Marketwired - Wed Dec 03, 7:03AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,257,753 in approved orders during November of 2014. This represents the third consecutive month that ScripsAmerica's specialty pharmacy generated over $5 million in sales.
WSA Speaks to Three Companies on the Rise
Marketwired - Tue Dec 02, 10:27AM CST
ClearOne (NASDAQ: CLRO) CEO Zee Hakimoglu discussed the company's favorable Q3 results reporting 27% revenue growth from last year with solid profitability. She outlined ClearOne's products and patents and talked about two recent acquisitions and how these acquisitions have positioned ClearOne favorably in their traditional audio conferencing market as well as in the emerging media collaboration market.
CLRO: 9.74 (-0.02)
SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20
ACCESSWIRE - Tue Dec 02, 8:01AM CST
New York, NY / ACCESSWIRE / December 2, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on ScripsAmerica, Inc. (OTCQB: SCRC) with a 12-month price target of $1.20.
ScripsAmerica Exercises Option to Acquire 90% of PIMD International, LLC
Marketwired - Mon Dec 01, 7:01AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that it has exercised an option to acquire 90% of PIMD International, LLC, ("PIMD"
, a Florida-based pharmaceutical wholesaler that the Company has had a working relationship with since the fourth quarter of 2013. ScripsAmerica Highlights CEO Interviews From Recent Investor Conference
Marketwired - Tue Nov 25, 7:00AM CST
ScripsAmerica Inc. (OTCBB: SCRC), today announced that its CEO, Bob Schneiderman, recently conducted interviews with financial outlets 'Stock News Now' (SNN) and 'New to the Street' (NTTS) at the SeeThru Equity Conference in NY.
ScripsAmerica Comments on Financial Results for the Third Quarter of 2014
Marketwired - Wed Nov 19, 3:51PM CST
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the third quarter ended September 30, 2014.
ScripsAmerica Announces Full Acquisition of Main Avenue Pharmacy
Marketwired - Wed Nov 19, 3:05PM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has recently acquired 100% of Main Avenue Pharmacy, Inc. ("MAVP"
, a New Jersey-based pharmacy that specializes in prescription topical creams. ScripsAmerica Announces Conference Call to Provide Business Update and Discuss Third Quarter Fiscal 2014 Results
Business Wire - Mon Nov 17, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that it will host a conference call at 10 a.m. Eastern Time, Wednesday, December 3, 2014 to comment on current business conditions and market drivers and to discuss various initiatives of the Company. Robert Schneiderman, Chief Executive Officer, Founding Partner and Jeffrey Andrews, Chief Financial Officer will also discuss the Company's recent 10-Q filing for the third quarter ended September 30, 2014 and conduct a question and answer session.
"New To The Street" Is Back on the Street
Marketwired - Thu Nov 13, 12:40PM CST
"New To The Street" was back on the street in NYC outside the See Thru Equity Conference, seethruequity.com, on 45th Street, interviewing several CEO's who were presenting at the micro-cap conference. We will be featuring these interviews on our website, NewToTheStreet.com on our segment called "On the Street Interviews."
DSKX: 0.69 (+0.01)
Small Cap Traders Provides Brief Report on ScripsAmerica
PR Newswire - Wed Nov 05, 6:00AM CST
Analyst Brief by Small Cap Traders. -- ScripsAmerica, Inc. (OTCBB: SCRC) is a supplier of prescription, OTC and nutraceutical drugs incepted in 2008 in the US. The firm provides pharmaceutical products to a wide range of end users including retail pharmacies, hospitals, long-term care facilities, government, and home care agencies. After experiencing a significant drop in profit margins in 2013, the firm restructured and has been experiencing a tremendous growth in both revenue and profit since the beginning of 2014. Q2 2014, ScripsAmerica reported $3,700,721 in total net revenue in compared to $91,628 reported during the same period in 2013, marking an increase of $3,609,093 in quarterly revenue. Also, profit margin in Q2 is 87%, in compare with a loss in 2013, signaling a positive trend for the firm. This growth in margin contributed to its management of the specialty pharmacy business which generated significant sales in the first six months of 2014.
Ironridge Global Partners, LLC Successfully Prevails in Federal Court Against Claims By ScripsAmerica, Inc.
ACCESSWIRE - Tue Nov 04, 3:03PM CST
LOS ANGELES, CA / ACCESSWIRE / November 4, 2014 / Ironridge Global Partners, LLC, an institutional investor in micro-cap public companies, today announced that the U.S. District Court has entered an order in favor of Ironridge Global Partners, granting its motion to dismiss the frivolous securities fraud claims filed by ScripsAmerica, Inc. (OTCQB: SCRC) in federal court, after ScripsAmerica's baseless claims against Ironridge Global IV, Ltd. had already been rejected by the California Superior Court.
ScripsAmerica Reports $5.6 Million in Approved Orders for Its Specialty Pharmacy in October
Marketwired - Tue Nov 04, 7:01AM CST
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $5,619,052 in approved orders during the month of October 2014, representing growth of 3% over the previous month and increasing its annual run rate to $67.4 million.
ScripsAmerica to Present at SeeThruEquity Microcap Investor Conference
Marketwired - Tue Oct 28, 7:06AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company will present at the SeeThruEquity Microcap Investor Conference to be held on Wednesday, November 12th at the Convene Midtown East in New York City.
ScripsAmerica's Specialty Pharmacy Reports $5.5 Million in Approved Orders for the Month of September
Marketwire - Mon Oct 06, 7:00AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $5,457,137 in approved orders during the month of September 2014. The pharmacy's September revenue represented a 12% increase over the previous month and increased its annual run rate to over $65 million.
ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement
Marketwire - Tue Sep 16, 7:02AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has entered into a prescription sourcing agreement with Ohio-based Jungle Jim's International Market, which has pharmacy licenses in several states.
ScripsAmerica Expands Specialty Pharmacy Operations Through Prescription Sourcing Agreement With United Apothecary, Inc.
Marketwire - Mon Sep 08, 7:03AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has signed a prescription sourcing agreement with United Apothecary, Inc., a pharmacy based in Oak Ridge, TN.
ScripsAmerica's Specialty Pharmacy Continues Revenue Growth With $4.9 Million in Approved Orders for August
Marketwire - Wed Sep 03, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,867,637 in approved orders during the month of August 2014, marking its fifth consecutive month of sales growth.
ScripsAmerica Comments on 10-Q for the Second Quarter of 2014
Marketwire - Mon Aug 18, 7:01AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the second quarter ended June 30, 2014.
Ironridge Global IV, Ltd. Successfully Obtains Final Enforcement Order Against ScripsAmerica, Inc.
ACCESSWIRE - Wed Aug 13, 3:31PM CDT
Los Angeles, CA / ACCESSWIRE / August 13, 2014 / Ironridge Global IV, Ltd. has obtained a final order against ScripsAmerica, Inc. (OTCBB: SCRC), fully upholding the original stipulated settlement agreement of the parties.
